Wells Fargo Maintains Overweight on DexCom, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on DexCom (NASDAQ:DXCM) and raised the price target from $80 to $90.
October 25, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo has maintained an Overweight rating on DexCom and increased the price target from $80 to $90, indicating a positive outlook.
The increase in price target from $80 to $90 by Wells Fargo suggests a positive outlook for DexCom, likely leading to a short-term increase in stock price. The Overweight rating indicates confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100